.Invite to today's Chutes & Ladders, our summary of substantial leadership hirings, shootings and...
.Observing a bad showing for Lykos Therapeutics' MDMA prospect for post-traumatic stress disorder at...
.AN2 Rehabs is reassessing its business in feedback to lackluster midphase records, pledging to give...
.Merck & Co. is actually spending $700 million ahead of time to test Amgen in a blood cancer cell...
.Along With Gilead Sciences on the verge of an FDA selection for its liver disease medicine seladelp...
.Chief executive officer David Ricks can easily see the firms putting together tents at basecamp res...
.Cushion Liquidators has switched Entero Therapies white as a slab. The lender got Entero to repay i...
.Exelixis is giving up on its cells factor (TF)- targeting antibody-drug conjugate after ending the ...
.Three full weeks after Roche's Genentech device bowed out an SHP2 inhibitor treaty, Relay Therapy h...
.Stoke Therapeutics' Dravet syndrome medication has been freed from a partial grip, getting rid of t...